• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Chlorfenapyr insecticidal nets provide strong protection against malaria in sub-Saharan Africa

byNeel MistryandTeddy Guo
April 6, 2022
in Infectious Disease, Pediatrics, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Chlorfenapyr LLINs provided significantly better protection than pyriproxyfen and piperonyl-butoxide subtypes.

2. Chlorfenapyr LLINs costed an additional $19 US than pyrethroid-only LLINs.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Pyrethroids have long been used to sustain effective malaria vector control. However, with growing resistance from Anopheles vectors, their effectiveness is slowly being compromised. New classes of long-lasting insecticidal nets (LLINs) are being developed to control the prevalence of malaria. This four-arm randomized trial aimed to compare the safety and efficacy of different dual-active-ingredient LLINs (pyriproxyfen, chlorfenapyr, and piperonyl butoxide) with pyrethroid-only LLINs against Plasmodium falciparum malaria infection. The primary outcome was prevalence of P. falciparum infection at 24 months from baseline while the primary economic outcome was cost-effectiveness of various dual-active-ingredient LLINs. According to study results, non-pyrethroid LLINs provided better protection than pyrethroid-only LLINs, although this difference was non-significant for the pyriproxyfen and piperonyl butoxide groups. In contrast, chlorfenapyr LLINs significantly reduced the rate of malaria infections and were found to be the most cost effective LLINs. A major limitation of this study is that it studied a single strain of malaria (P. falciparum) in a single nation of sub-Saharan Africa.

Click to read the study in The Lancet

Relevant Reading: A Monoclonal Antibody for Malaria Prevention

In-depth [randomized-controlled trial]: Between May 11 and July 2, 2018, 86 clusters were screened for eligibility in Misungwi, Tanzania. To be included, clusters must have at least 119 households containing children aged 6 months to 14 years. Altogether, 84 clusters (21 each to pyrethroid-only, pyriproxyfen, chlorfenapyr, and piperonyl-butoxide groups) were included in the intention-to-treat analysis. The primary outcome of malaria infection at 24 months was lower in the pyriproxyfen (37.5%, adjusted odds ratio [aOR] 0.79, 95% confidence interval [CI] 0.54-1.17, p=0.2354), piperonyl-butoxide (40.7%, aOR 0.99, 95% CI 0.67-1.45, p=0.9607), and chlorfenapyr (25.6%, aOR 0.45, 95% CI 0.30-0.67, p=0.0001) groups compared to pyrethroid-only reference group (45.8%). However, only chlorfenapyr LLINs provided significantly better protection at two years than pyrethroid-only LLINs. Chlorfenapyr LLINs were also the most cost-effective, costing only $19 more than standard pyrethroid-only LLINs. The most common side effects included skin irritation or paresthesia. Overall, chlorfenapyr LLINs provided significantly better protection than standard LLINs and may be considered for malaria prevention in sub-Saharan Africa.

RELATED REPORTS

Vaccines for Zaire Ebola virus disease are safe and generate an immune response

Oral BPaLM regimen is noninferior to standard of care for rifampin-resistant tuberculosis

Evolving standard of care guidelines have improved outcomes in hospitalized COVID-19 patients

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: global healthinfectious diseaselong-lasting insecticidal nets (LLIN)malariamalaria controlPlasmodium falciparumsub-Saharan Africa
Previous Post

Glyburide non-inferior to insulin for perinatal outcomes in gestational diabetes

Next Post

Subcortical neurons associated with sleep disturbances in neurodegenerative disease

RelatedReports

2 Minute Medicine Rewind November 23 – November 30, 2014
Emergency

Vaccines for Zaire Ebola virus disease are safe and generate an immune response

January 4, 2023
Shorter moxifloxacin-containing regimens ineffective for treating TB [REMoxTB trial]
Chronic Disease

Oral BPaLM regimen is noninferior to standard of care for rifampin-resistant tuberculosis

January 4, 2023
Palliative chemotherapy associated with more ICU treatment at end-of-life
Infectious Disease

Evolving standard of care guidelines have improved outcomes in hospitalized COVID-19 patients

December 23, 2022
N95 masks may have similar efficacy to medical masks for influenza prevention
Infectious Disease

Medical masks do not demonstrate definitive noninferiority to N95 respirators in preventing COVID-19

December 23, 2022
Next Post
Combined MRI and NIH stroke scores may predict stroke prognosis

Subcortical neurons associated with sleep disturbances in neurodegenerative disease

#VisualAbstract: IL-17 inhibitors are associated with higher treatment persistence than TNF inhibitors in patients with psoriasis and psoriatic arthritis

#VisualAbstract: IL-17 inhibitors are associated with higher treatment persistence than TNF inhibitors in patients with psoriasis and psoriatic arthritis

Women electing abortion more likely to be victims of domestic violence

Presence of second midwife during the second active stage of labour reduces the risk of severe perineal trauma

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher body mass index may be associated with altered vitamin D levels and metabolism
  • #VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
  • Community-based adult vision screening program increases access to eye care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options